Literature DB >> 16401148

Safety issues with drug therapies for autism spectrum disorders.

James T McCracken1.   

Abstract

Although currently no medication has been approved to treat autism spectrum disorders, survey data show that community practitioners are prescribing a broad range of medication treatments, including, but not limited to, antidepressants, stimulants, antipsychotics, alpha agonists, and anticonvulsants. Patients with autism spectrum disorders are also taking alternative treatments, including herbal remedies, immunologic treatments, and vitamin therapies, which may themselves produce side effects and/or create drug interactions with traditional medications. Although short-term data on the efficacy and safety of commonly prescribed treatments for autism spectrum disorders are increasing, few data are currently available on long-term treatment for autism spectrum disorders, but available studies and clinical experience can offer preliminary recommendations on the safety of and monitoring needs for the medications currently used for these disorders. Monitoring the safety and tolerability of drugs used in patients with these disorders should minimize the burden of side effects and optimize treatment outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401148

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

1.  Managing anxiety and depressive symptoms in adults with autism-spectrum disorders.

Authors:  Kerry Boyd; Marc Woodbury-Smith; Peter Szatmari
Journal:  J Psychiatry Neurosci       Date:  2011-07       Impact factor: 6.186

2.  Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analysts.

Authors:  Marc Weeden; Kristal Ehrhardt; Alan Poling
Journal:  Behav Anal Pract       Date:  2010

Review 3.  [Psychopharmacology of autism spectrum disorders].

Authors:  L Poustka; T Banaschewski; F Poustka
Journal:  Nervenarzt       Date:  2011-05       Impact factor: 1.214

Review 4.  Progress of mesenchymal stem cell therapy for neural and retinal diseases.

Authors:  Tsz Kin Ng; Veronica R Fortino; Daniel Pelaez; Herman S Cheung
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

5.  Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey.

Authors:  Lynn K Koegel; Anna M Krasno; Howard Taras; Robert L Koegel; William Frea
Journal:  School Ment Health       Date:  2013-02-06

6.  Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

Authors:  Michael Aman; Mallikarjuna Rettiganti; Haikady N Nagaraja; Jill A Hollway; James McCracken; Christopher J McDougle; Elaine Tierney; Lawrence Scahill; L Eugene Arnold; Jessica Hellings; David J Posey; Naomi B Swiezy; Jaswinder Ghuman; Marco Grados; Bhavik Shah; Benedetto Vitiello
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-08       Impact factor: 2.576

7.  Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.

Authors:  Gabriel S Dichter; Cara A Damiano; John A Allen
Journal:  J Neurodev Disord       Date:  2012-07-06       Impact factor: 4.025

Review 8.  Long-term consequences of drugs on the paediatric cardiovascular system.

Authors:  Elizabeth Hausner; Monica L Fiszman; Joseph Hanig; Patricia Harlow; Gwen Zornberg; Solomon Sobel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 9.  Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?

Authors:  Dario Siniscalco; Anna Sapone; Alessandra Cirillo; Catia Giordano; Sabatino Maione; Nicola Antonucci
Journal:  J Biomed Biotechnol       Date:  2012-02-13

10.  Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.

Authors:  Alessandro S De Nadai; Eric A Storch; Joseph F McGuire; Adam B Lewin; Tanya K Murphy
Journal:  J Cent Nerv Syst Dis       Date:  2011-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.